Andrew Guggenhime insider trades: Vaxcyte (PCVX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrew reports to the SEC
Open-market buys and sales
38 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | PCVX | ↓ Sell | 10,000 | $53.89 | $539K | Direct | Aug 5, 2026 (2d) |
| Jul 6, 2026 | PCVX | ↓ Sell | 10,000 | $57.28 | $573K | Direct | Jul 6, 2026 (0d) |
| Jun 18, 2026 | PCVX | ↓ Sell | 10,000 | $53.00 | $530K | Direct | Jun 18, 2026 (0d) |
| Feb 18, 2025 | PCVX | ↓ Sell | 8,000 | $83.85 | $671K | Direct | Feb 19, 2025 (1d) |
| Jan 21, 2025 | PCVX | ↓ Sell | 8,000 | $86.51 | $692K | Direct | Jan 22, 2025 (1d) |
| Dec 18, 2024 | PCVX | ↓ Sell | 8,000 | $88.78 | $710K | Direct | Dec 19, 2024 (1d) |
| Nov 18, 2024 | PCVX | ↓ Sell | 8,000 | $85.81 | $687K | Direct | Nov 19, 2024 (1d) |
| Oct 18, 2024 | PCVX | ↓ Sell | 42,000 | $115.39 | $4.8M | Direct | Oct 22, 2024 (4d) |
| Sep 18, 2024 | PCVX | ↓ Sell | 8,000 | $115.94 | $928K | Direct | Sep 19, 2024 (1d) |
| Aug 19, 2024 | PCVX | ↓ Sell | 8,000 | $78.58 | $629K | Direct | Aug 20, 2024 (1d) |
| Jul 18, 2024 | PCVX | ↓ Sell | 8,000 | $81.17 | $649K | Direct | Jul 22, 2024 (4d) |
| Jun 18, 2024 | PCVX | ↓ Sell | 8,000 | $71.92 | $575K | Direct | Jun 20, 2024 (2d) |
| May 20, 2024 | PCVX | ↓ Sell | 8,000 | $74.99 | $600K | Direct | May 22, 2024 (2d) |
| Apr 18, 2024 | PCVX | ↓ Sell | 8,000 | $61.27 | $490K | Direct | Apr 22, 2024 (4d) |
| Mar 18, 2024 | PCVX | ↓ Sell | 8,000 | $69.02 | $552K | Direct | Mar 20, 2024 (2d) |
| Feb 20, 2024 | PCVX | ↓ Sell | 8,000 | $74.53 | $596K | Direct | Feb 22, 2024 (2d) |
| Jan 18, 2024 | PCVX | ↓ Sell | 8,000 | $60.73 | $486K | Direct | Jan 19, 2024 (1d) |
| Dec 18, 2023 | PCVX | ↓ Sell | 8,000 | $60.18 | $481K | Direct | Dec 20, 2023 (2d) |
| Dec 14, 2023 | PCVX | ↓ Sell | 14,000 | $60.22 | $843K | Direct | Dec 18, 2023 (4d) |
| Nov 20, 2023 | PCVX | ↓ Sell | 8,000 | $51.13 | $409K | Direct | Nov 22, 2023 (2d) |
| Oct 18, 2023 | PCVX | ↓ Sell | 8,000 | $45.91 | $367K | Direct | Oct 20, 2023 (2d) |
| Sep 19, 2022 | PCVX | ↓ Sell | 3,100 | $26.10 | $81K | Direct | Sep 21, 2022 (2d) |
| Aug 29, 2022 | PCVX | ↓ Sell | 36,000 | $28.00 | $1.0M | Direct | Aug 29, 2022 (0d) |
| Aug 18, 2022 | PCVX | ↓ Sell | 3,100 | $25.26 | $78K | Direct | Aug 22, 2022 (4d) |
| Jul 18, 2022 | PCVX | ↓ Sell | 3,100 | $24.53 | $76K | Direct | Jul 20, 2022 (2d) |
| Jul 8, 2022 | PCVX | ↓ Sell | 3,100 | $24.00 | $74K | Direct | Jul 12, 2022 (4d) |
| May 18, 2022 | PCVX | ↓ Sell | 3,100 | $24.44 | $76K | Direct | May 20, 2022 (2d) |
| Apr 18, 2022 | PCVX | ↓ Sell | 3,100 | $24.05 | $75K | Direct | Apr 20, 2022 (2d) |
| Mar 18, 2022 | PCVX | ↓ Sell | 3,100 | $26.13 | $81K | Direct | Mar 22, 2022 (4d) |
| Mar 1, 2022 | PCVX | ↓ Sell | 6,200 | $24.00 | $149K | Direct | Mar 3, 2022 (2d) |
| Dec 23, 2021 | PCVX | ↓ Sell | 3,100 | $24.00 | $74K | Direct | Dec 28, 2021 (5d) |
| Nov 18, 2021 | PCVX | ↓ Sell | 3,100 | $24.53 | $76K | Direct | Nov 22, 2021 (4d) |
| Nov 9, 2016 | DERM | ↓ Sell | 4,100 | $35.02 | $144K | Direct | Nov 10, 2016 (1d) |
| Oct 11, 2016 | DERM | ↓ Sell | 10,900 | $34.34 | $374K | Direct | Oct 13, 2016 (2d) |
| Sep 19, 2016 | DERM | ↓ Sell | 15,000 | $35.01 | $525K | Direct | Sep 20, 2016 (1d) |
| Sep 12, 2016 | DERM | ↓ Sell | 10,000 | $32.53 | $325K | Direct | Sep 14, 2016 (2d) |
| Aug 11, 2016 | DERM | ↓ Sell | 10,000 | $31.02 | $310K | Direct | Aug 12, 2016 (1d) |
| Jul 11, 2016 | DERM | ↓ Sell | 10,000 | $30.15 | $302K | Direct | Jul 12, 2016 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PCVX insiders
Open-market trades in the last 12 months
About Andrew Guggenhime's insider trades
Andrew Guggenhime is President and CFO at Vaxcyte (PCVX). Since Jul 11, 2016, Andrew has reported no open-market purchases and 38 sales worth $20.7M on SEC Form 4. In the last 12 months: 3 sales ($1.6M).
Their filings also include option exercises (46 filings), grants and awards (29 filings), shares withheld for taxes (19 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCVX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.